No left-side outlet ran this
← All coverage gaps
2026-10-16 19:02
South Africa tightens rules on weight-loss drugs
67%33%
3 outlets · Left 0 · Center 2 · Right 1
How each side titled it
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
Who got there first
each line: one outlet's first article — above the track left · below right · across center
First reported by Fox News (Right); 3 outlets over 20h.
Fox News · +18h Reuters · +20h Semafor
What each side is saying
- SemaforCenter
Pharmaceutical giants Novo Nordisk and Eli Lilly have sought to curb the pharmacy-made products competing with their blockbuster GLP-1 drugs.
Read at semafor.com → - ReutersCenter
Eli Lilly's weight-loss pill wins EU drug regulator's backing Reuters
Read at reuters.com → - Fox NewsRight
GLP-1 medications like semaglutide and tirzepatide are repairing joints, calming inflammation, and protecting vital organs before any weight loss occurs.
Read at foxnews.com →
Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
3 articles, newest first · filter by side
location
SemaforCenter
South Africa tightens rules on weight-loss drugs
Read at semafor.com →ReutersCenter
Eli Lilly's weight-loss pill wins EU drug regulator's backing - Reuters
Read at reuters.com →Fox NewsRight
Weight-loss drugs may fight 7 serious health problems before the pounds even come off
Read at foxnews.com →Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.